Science Corp. Plans First Human Trial of Biohybrid Brain Sensor

Wed, 15 Apr 2026 01:23:00 +0200

Science Corporation, the startup founded by former Neuralink president Max Hodak, is preparing to conduct its first human trial of a biohybrid brain-computer interface. The company has recruited Dr. Murat Günel, chair of Yale Medical School’s Department of Neurosurgery, as a scientific adviser. The initial trial will involve placing a sensor on the surface of the brain in patients already undergoing significant brain surgery. Unlike Neuralink’s devices, this sensor does not penetrate brain tissue and contains 520 recording electrodes within a pea-sized device. The long-term vision for Science Corp. is to integrate lab-grown neurons with electronics to create a biological interface that could improve neurological therapies and potentially enhance human capabilities. The company’s most advanced current product is PRIMA, a vision restoration device for patients with macular degeneration, which is progressing through clinical trials in Europe. The team, led by co-founder and chief science